BMEA

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Biomea Fusion Inc

NASDAQ | BMEA

1.26

USD

$0.00

(

0.00%

)

At Close (As of Nov 4, 2025)

$89.09M

Market Cap

-

P/E Ratio

-2.89

EPS

$8.99

52 Week High

$1.24

52 Week Low

HEALTHCARE

Sector

BMEA Chart

Recent Chart
Price Action

BMEA Technicals

Tags:

BMEA Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$144M
Selling General And Administrative $26M
Research And Development $118M
Operating Expenses $144M
Investment Income Net -
Net Interest Income $5.6M
Interest Income $5.6M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.7M
Income Before Tax -$138M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$138M
Comprehensive Income Net Of Tax -
Ebit -$138M
Ebitda -$137M
Net Income -$138M

Revenue & Profitability

Earnings Performance

BMEA Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $80M
Total Current Assets $68M
Cash And Cash Equivalents At Carrying Value $58M
Cash And Short Term Investments $58M
Inventory -
Current Net Receivables -
Total Non Current Assets $12M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $10M
Other Non Current Assets -
Total Liabilities $28M
Total Current Liabilities $22M
Current Accounts Payable $13M
Deferred Revenue -
Current Debt -
Short Term Debt $2.1M
Total Non Current Liabilities $6.7M
Capital Lease Obligations $8.8M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $8.8M
Other Current Liabilities $6.7M
Other Non Current Liabilities -
Total Shareholder Equity $52M
Treasury Stock -
Retained Earnings -$387M
Common Stock $4K
Common Stock Shares Outstanding $36M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$120M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.7M
Capital Expenditures $362K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$362K
Cashflow From Financing $1.7M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$138M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$144M
Selling General And Administrative $26M
Research And Development $118M
Operating Expenses $144M
Investment Income Net -
Net Interest Income $5.6M
Interest Income $5.6M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.7M
Income Before Tax -$138M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$138M
Comprehensive Income Net Of Tax -
Ebit -$138M
Ebitda -$137M
Net Income -$138M

BMEA News

BMEA Profile

Biomea Fusion Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Biomea Fusion Inc. is an innovative biopharmaceutical company headquartered in Redwood City, California, focused on developing cutting-edge irreversible small molecules for the treatment of genetically defined cancers. By harnessing advanced scientific methodologies, Biomea aims to meet the significant unmet medical needs of patients with specific genetic mutations, thereby establishing itself as a leader in the field of targeted cancer therapies. With a robust clinical pipeline and a strategic focus on commercialization, Biomea is well-positioned to make a transformative impact on patient care and the oncology landscape.

CHR
-45.66%
$0.07
NVVE
-5.52%
$0.19
MTC
+409.86%
$1.55
ASST
+18.80%
$1.48
RIVN
+23.70%
$15.46
BYND
-4.31%
$1.33
LNAI
+45.09%
$1.21
VHAI
0.00%
$0.00
NVDA
-1.61%
$195.48
GPUS
+8.87%
$0.38
PLUG
-8.36%
$2.52
RUBI
-49.75%
$0.30
PFE
+1.29%
$24.61
SLDP
+51.55%
$8.51
YDKG
-5.55%
$0.05
ETHD
+20.91%
$5.26
SMX
+38.80%
$2.04
T
-0.36%
$24.44
TSLA
+3.71%
$460.75
SOFI
-4.11%
$29.37
PLTR
-1.60%
$187.67
DNN
-2.18%
$2.68
AXDX
-61.36%
$0.03
F
+2.85%
$13.15
AMD
+2.51%
$256.33
PINS
-22.92%
$25.36
ACHR
+0.26%
$9.58
AAL
+6.08%
$13.42
BITF
+6.11%
$4.07
CIFR
+9.77%
$24.71
WTO
-1.40%
$0.04
SMCI
-11.11%
$42.13
TEVA
+20.16%
$24.58
INTC
+3.96%
$38.50
BAC
-2.04%
$52.44
SNAP
-2.45%
$7.28
KVUE
+1.94%
$16.28
ADAP
-15.14%
$0.05
ONDS
-0.25%
$5.94
NFE
+13.99%
$1.53
AMCR
+3.04%
$8.11
BTG
+1.12%
$4.04
IREN
-1.65%
$66.63
RXRX
-8.08%
$5.00
VALE
+3.09%
$12.31
DVLT
-7.83%
$1.64
RGTI
+5.99%
$37.29
MARA
+3.70%
$17.23
RMBL
+60.50%
$3.21
JOBY
-9.55%
$14.76
RIG
+0.38%
$3.91
ADD
-25.47%
$0.05
WBD
+0.53%
$22.71
BURU
-2.17%
$0.28
QS
+9.93%
$16.97
GRAB
-2.76%
$5.62
WULF
+2.46%
$15.38
CAN
+14.43%
$1.27
BTBT
+3.14%
$3.28
EPWK
-7.75%
$0.06
FUBO
+11.27%
$4.09
SRM
+53.27%
$10.30
TLRY
+3.62%
$1.28
NVO
+1.01%
$48.73
ZDAI
+13.94%
$0.52
U
+17.45%
$42.13
HIMS
+3.11%
$44.12
NOK
+0.51%
$6.84
APPS
+23.14%
$7.29
HTZ
-0.81%
$6.67
ALIT
-7.22%
$2.50
BMNR
+4.96%
$41.42
KDLY
-11.88%
$0.78
NGD
+2.48%
$6.80
NIO
+2.30%
$7.32
NVTS
-5.73%
$9.86
WLGS
-5.57%
$0.04
CGC
-5.83%
$1.12
RIOT
-2.90%
$18.71
HPE
+0.59%
$23.70
PCG
+1.05%
$16.32
AG
-7.82%
$10.65
ETWO
0.00%
$3.30
HOOD
-6.98%
$136.80
RDHL
+0.88%
$1.08
NCLH
-1.25%
$18.55
ITUB
+1.55%
$7.49
AMZN
-0.36%
$248.42
BW
+38.55%
$5.18
CMG
+0.96%
$32.04
QBTS
+4.90%
$31.19
GOOGL
+2.47%
$284.42
MSPR
-27.89%
$0.47
AAPL
-0.18%
$269.53
IONZ
-7.18%
$4.14
SOUN
+2.36%
$15.48
TREX
-31.07%
$32.42
PLTD
+1.97%
$6.47
PLTZ
+2.69%
$6.23
AFMD
-34.94%
$0.18
CHR
-45.66%
$0.07
NVVE
-5.52%
$0.19
MTC
+409.86%
$1.55
ASST
+18.80%
$1.48
RIVN
+23.70%
$15.46
BYND
-4.31%
$1.33
LNAI
+45.09%
$1.21
VHAI
0.00%
$0.00
NVDA
-1.61%
$195.48
GPUS
+8.87%
$0.38
PLUG
-8.36%
$2.52
RUBI
-49.75%
$0.30
PFE
+1.29%
$24.61
SLDP
+51.55%
$8.51
YDKG
-5.55%
$0.05
ETHD
+20.91%
$5.26
SMX
+38.80%
$2.04
T
-0.36%
$24.44
TSLA
+3.71%
$460.75
SOFI
-4.11%
$29.37
PLTR
-1.60%
$187.67
DNN
-2.18%
$2.68
AXDX
-61.36%
$0.03
F
+2.85%
$13.15
AMD
+2.51%
$256.33
PINS
-22.92%
$25.36
ACHR
+0.26%
$9.58
AAL
+6.08%
$13.42
BITF
+6.11%
$4.07
CIFR
+9.77%
$24.71
WTO
-1.40%
$0.04
SMCI
-11.11%
$42.13
TEVA
+20.16%
$24.58
INTC
+3.96%
$38.50
BAC
-2.04%
$52.44
SNAP
-2.45%
$7.28
KVUE
+1.94%
$16.28
ADAP
-15.14%
$0.05
ONDS
-0.25%
$5.94
NFE
+13.99%
$1.53
AMCR
+3.04%
$8.11
BTG
+1.12%
$4.04
IREN
-1.65%
$66.63
RXRX
-8.08%
$5.00
VALE
+3.09%
$12.31
DVLT
-7.83%
$1.64
RGTI
+5.99%
$37.29
MARA
+3.70%
$17.23
RMBL
+60.50%
$3.21
JOBY
-9.55%
$14.76
RIG
+0.38%
$3.91
ADD
-25.47%
$0.05
WBD
+0.53%
$22.71
BURU
-2.17%
$0.28
QS
+9.93%
$16.97
GRAB
-2.76%
$5.62
WULF
+2.46%
$15.38
CAN
+14.43%
$1.27
BTBT
+3.14%
$3.28
EPWK
-7.75%
$0.06
FUBO
+11.27%
$4.09
SRM
+53.27%
$10.30
TLRY
+3.62%
$1.28
NVO
+1.01%
$48.73
ZDAI
+13.94%
$0.52
U
+17.45%
$42.13
HIMS
+3.11%
$44.12
NOK
+0.51%
$6.84
APPS
+23.14%
$7.29
HTZ
-0.81%
$6.67
ALIT
-7.22%
$2.50
BMNR
+4.96%
$41.42
KDLY
-11.88%
$0.78
NGD
+2.48%
$6.80
NIO
+2.30%
$7.32
NVTS
-5.73%
$9.86
WLGS
-5.57%
$0.04
CGC
-5.83%
$1.12
RIOT
-2.90%
$18.71
HPE
+0.59%
$23.70
PCG
+1.05%
$16.32
AG
-7.82%
$10.65
ETWO
0.00%
$3.30
HOOD
-6.98%
$136.80
RDHL
+0.88%
$1.08
NCLH
-1.25%
$18.55
ITUB
+1.55%
$7.49
AMZN
-0.36%
$248.42
BW
+38.55%
$5.18
CMG
+0.96%
$32.04
QBTS
+4.90%
$31.19
GOOGL
+2.47%
$284.42
MSPR
-27.89%
$0.47
AAPL
-0.18%
$269.53
IONZ
-7.18%
$4.14
SOUN
+2.36%
$15.48
TREX
-31.07%
$32.42
PLTD
+1.97%
$6.47
PLTZ
+2.69%
$6.23
AFMD
-34.94%
$0.18
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.